Log in
NASDAQ:KRTX

Karuna Therapeutics Price Target, Predictions & Analyst Ratings

$100.00
+2.01 (+2.05 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$98.00
Now: $100.00
$101.60
50-Day Range
$75.23
MA: $89.13
$107.49
52-Week Range
$52.62
Now: $100.00
$123.73
Volume117,678 shs
Average Volume259,737 shs
Market Capitalization$2.68 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.63

Analyst Ratings

Karuna Therapeutics (NASDAQ:KRTX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for Karuna Therapeutics in the last 12 months. Their average twelve-month price target is $127.91, predicting that the stock has a possible upside of 27.91%. The high price target for KRTX is $150.00 and the low price target for KRTX is $105.00. There are currently 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
KRTX Consensus Rating: BuyBuyBuyBuy
KRTX Consensus Rating Score: 3.003.003.003.00
KRTX Analyst Ratings: 0 Sell Rating(s)
0 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
KRTX Consensus Price Target: $127.91$125.70$125.70$115.82
KRTX Price Target Upside: 27.91% upside38.15% upside38.15% upside53.97% upside

Karuna Therapeutics (NASDAQ:KRTX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Karuna Therapeutics (NASDAQ:KRTX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/19/2020Maxim GroupInitiated CoverageBuy$150.00Medium
8/11/2020William BlairReiterated RatingBuyMedium
8/6/2020HC WainwrightReiterated RatingBuy$140.00 ➝ $130.00Low
6/24/2020OppenheimerBoost Price TargetPositive ➝ Outperform$125.00 ➝ $135.00Medium
6/23/2020MizuhoReiterated RatingBuy$116.00High
6/3/2020Stifel NicolausBoost Price TargetBuy$126.00 ➝ $135.00Low
6/2/2020WedbushBoost Price TargetOutperform$117.00 ➝ $126.00Low
6/1/2020The Goldman Sachs GroupBoost Price TargetBuy$115.00 ➝ $131.00Medium
3/31/2020GuggenheimInitiated CoverageBuy$120.00Low
1/22/2020Wells Fargo & CompanyBoost Price TargetOverweight$106.00 ➝ $137.00Medium
1/9/2020JMP SecuritiesInitiated CoverageOutperform$122.00Medium
7/23/2019CitigroupInitiated CoverageBuy ➝ Buy$28.00High
(Data available from 11/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.